Available evidence also shows that BC cells have significantly higher insulin receptor (IR) levels than normal breast cells [7], suggesting that this signaling pathway may play a role in BC development and progression, and may become a potential therapeutic target. The gene discussed is INSR; the disease is breast cancer.